Vanguard Personalized Indexing Management’s Tandem Diabetes Care TNDM Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,105	Closed	-$217K	–	1869
2024 Q3	$217K	Buy	+5,105	New	+$216K	﹤0.01%	1494
2024 Q2	–	Sell	-5,654	Closed	-$200K	–	1747
2024 Q1	$200K	Buy	+5,654	New	+$151K	﹤0.01%	1450
2023 Q2	–	Sell	-8,598	Closed	-$349K	–	1528
2023 Q1	$349K	Buy	8,598 +3,933	+84%	+$163K	0.01%	1041
2022 Q4	$210K	Buy	+4,665	New	+$211K	0.01%	1136
2022 Q3	–	Sell	-5,708	Closed	-$338K	–	1309
2022 Q2	$338K	Buy	5,708 +134	+2%	+$11K	0.02%	946
2022 Q1	$648K	Buy	5,574 +364	+7%	+$42.5K	0.03%	693
2021 Q4	$784K	Buy	+5,210	New	+$703K	0.05%	513

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Vanguard Personalized Indexing Management's TNDM Position: Q4 2024 in Review

Vanguard Personalized Indexing Management sold out of Tandem Diabetes Care (TNDM) in Q4 2024, closing a stake of 5,105 shares — an estimated $217K sold.

Vanguard Personalized Indexing Management first reported a position in TNDM in Q4 2021 and held it in 7 quarters. The position peaked at $784K in Q4 2021. 316 funds tracked by Wall St. Rank hold TNDM as of Q4 2024.

Vanguard Personalized Indexing Management reported no remaining Tandem Diabetes Care position as of Q4 2024 after selling out during the quarter.
Vanguard Personalized Indexing Management sold 5,105 Tandem Diabetes Care shares in Q4 2024, an estimated $217K.
Vanguard Personalized Indexing Management first reported a position in Tandem Diabetes Care in Q4 2021 and held it in 7 quarters.
Vanguard Personalized Indexing Management's Tandem Diabetes Care position peaked at $784K in Q4 2021.
316 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2024.

Based on Vanguard Personalized Indexing Management's 13F filing for Q4 2024, filed 10 Feb 2025.